Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection-Reference-Cited by-同舟云学术

Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection

Published:2017-05-03 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zou Zhong,Huang Kun,Wei Yanmin,Chen Huanchun,Liu Ziduo,Jin Meilin

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-01554-1.pdf

Reference51 articles.

1. Sturm-Ramirez, K. M. et al. Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? Journal of virology 79, 11269–11279, doi: 10.1128/JVI.79.17.11269-11279.2005 (2005).

2. Su, J. et al. Duck egg-drop syndrome caused by BYD virus, a new Tembusu-related flavivirus. PloS one 6, e18106, doi: 10.1371/journal.pone.0018106 (2011).

3. Newcomb, S. S. Duck virus enteritis (duck plague) epizootiology and related investigations. Journal of the American Veterinary Medical Association 153, 1897–1902 (1968).

4. Xu, X., Subbarao, K., Cox, N. J. & Guo, Y. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261, 15–19, doi: 10.1006/viro.1999.9820 (1999).

5. Chen, H. et al. The evolution of H5N1 influenza viruses in ducks in southern China. Proceedings of the National Academy of Sciences of the United States of America 101, 10452–10457, doi: 10.1073/pnas.0403212101 (2004).

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies;Vaccines;2024-06-07

2. Genome editing and its role in vaccine, diagnosis, and therapeutic advancement;International Journal of Biological Macromolecules;2024-06

3. CRISPR Cas-9 for treatment and control of Avian viral diseases: challenges and opportunities;World's Poultry Science Journal;2024-05-15

4. Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications;Virus Research;2024-03

5. Self-assembled nanoparticle with E protein domain III of DTMUV based on ferritin as carrier can induce a more comprehensive immune response and against DTMUV challenge in duck;Veterinary Microbiology;2023-09